Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Not pending/lapsed |
21 | DE file number | DAKZ | 603 48 544.8 |
96 | EP file number | EAKZ | 09 00 7539.1 |
97 | EP publication number | EPN | 2100615 |
54 | Designation/title | TI | Krebstherapie |
51 | IPC main class | ICM (ICMV) | A61K 39/00 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61P 35/00 (2006.01), G01N 33/68 (2006.01), G01N 33/574 (2006.01) |
22 | DE application date | DAT | Feb 14, 2003 |
96 | EP application date | EAT | Feb 14, 2003 |
43 | Date of first publication | OT | Sep 16, 2009 |
| Date of publication of grant | PET | Feb 10, 2016 |
71/73 | Applicant/owner | INH | Biotempus Pty Ltd, Melbourne, Victoria, AU |
72 | Inventor | IN | Ashdown, Martin Leonard, Victoria 3071, AU |
74 | Representative | VTR | Maiwald GmbH, 80335 München, DE |
| Address for service | | Maiwald GmbH, 80065 München, DE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| AU PS054702 Feb 14, 2002
|
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PT, SE, SI, SK, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000002100615 Searchable text:
EP000002100615 Original document:
EP000002100615B1 Searchable text:
EP000002100615B1 |
43 | Date of first publication | EVT | Sep 16, 2009 |
| Date of the first transfer into DPMAregister | EREGT | May 27, 2011 |
| Date of the (most recent) update in DPMAregister | REGT | Nov 12, 2024 (Show all update days)(Hide all update days)- Nov 12, 2024
- Status: changed
- Procedures: Administrative procedure, IP right lapsed through expiry of term of protection, 14.02.2023: new
- Nov 5, 2024
- St.36: changed (technical change)
- May 27, 2011
- Date of the first transfer into DPMAregister
|